09-29-2017 03:01 PM CET - Advertising, Media Consulting, Marketing Research
Print

Global Sleep Apnea Market: Top Key Players are RESMED, KONINKLIJKE PHILIPS N.V., FISHER & PAYKEL

Press release from: Data Bridge Market Research
Global Sleep Apnea Market
Global Sleep Apnea Market
Global Sleep Apnea Market is expected to reach USD 14,119.5 million by 2024 from USD 7,800.0 million in 2016, at a CAGR of 7.7% in the forecast period 2017 to 2024. The new market report contains data for historic years 2015, the base year of calculation is 2016 and the forecast period is 2017 to 2024.

Request For Sample: databridgemarketresearch.com/request-a-sample/?dbmr=globa...

The global sleep apnea devices market is highly concentrated to a few big players and rest to local players who cater to domestic markets only. Resmed dominated the sleep apnea devices market accounting for a highest market share in 2016, followed by Philips Respironics, and Fisher Paykel, Somnetics, Inc. Other players in this market include Somnetics, Inc., Apex Medical, DeVilbiss and SomnoMedSomnetics International, Inc, Nox Medical, Natus Medical, SomnoMedics GmbH, Philips Respironics and Cadwell Industries, Inc., Nihon Kohden, Compumedics Limited.(Australia), Contec Medical System Co.Ltd.(China) and Becton Dickinson & Company (Carefusion) among others holds 29.7% of the global sleep apnea devices market in 2016.

This report consists of below pages:
• No of pages: 400
• No of Figures: 20
• No of Tables: 341

Browse Full Report: databridgemarketresearch.com/reports/global-sleep-apnea-d...

RESMED:

ResMed was founded in 1989 and is headquartered at California, USA. It focuses on manufacturing devices that can be used for diagnosing, treating and managing sleep apnea, chronic obstructive pulmonary disease (COPD) and other chronic diseases.

Recent developments:

In January, 2017, ResMed launched Sleep Score Labs is a joint venture between renowned surgeon and television host Dr. Mehmet Oz; ResMed, the global leader in medical devices and digital connected care; and private equity firm Pegasus Capital Advisors, L.P., which invests in companies focused on sustainability and wellness.

In November, 2016, ResMed introduced two masks named the AirFit N20 nasal mask and AirFit F20 full face mask for positive airway pressure (PAP) treatment of sleep apnea. The masks are innovatively designed to improve mask fit, comfort and ease of use, the new-generation ResMed masks are the result of more than three years of research and development.

In November, 2016, ResMed announced two enhancements to AirView, the world’s largest cloud-based remote patient monitoring platform that enables care teams to securely access therapy data from three million sleep apnea and respiratory care patients every day. AirView Action Groups automatically filters a clinician’s sleep apnea patients on positive airway pressure (PAP) therapy into actionable groups based on adherence status or a specific therapy issue they may be having. This will help in reducing time of clinicians and also help patients in getting more responsive and quality treatment.

KONINKLIJKE PHILIPS N.V.:

Koninklijke Philips N.V. was founded in 1976 and headquartered in Murrysville, Pennsylvania, U.S. Koninklijke Philips N.V. focuses on developing, manufacturing and distributing products for personal health, diagnosis & treatment, connected care & health informatics, health tech and many more. For sleep apnea devices, Koninklijke Philips N.V.has devices in diagnosis and treatment segment

Recent developments:

In January, 2017, Philips and Bon Secours Charity Health System announce USD180 million, long-term strategic partnership to support transformation of patient care and build healthier communities

In February, 2017, Philips announced about partnering with the Mackenzie Innovation Institute (Mi2) in Canada on opportunities to develop, test and evaluate technological solutions and innovations intended to improve patient care across the healthcare system.

In March, 2017, Koninklijke Philips N.V. announced that it has signed an agreement to acquire Australian Pharmacy SleepServices (APSS). It will help Philips to provide better access to home sleep testing for those who need it, where and when they need it.

FISHER & PAYKEL:

Fisher and Paykel Healthcare Limited was founded in 1971 and is headquartered at Auckland, New Zealand. The company is focused in designing innovative medical products and therapies which meet the needs of patients and their caregivers. The company entered the respiratory care market by developing the unique respiratory humidifier system. The company now offers a broad range of products and systems for the use in respiratory care and acute care and thus in the treatment of obstructive sleep apnea (OSA).

Recent Developments:

In August, 2016, Fisher &Paykel Healthcare Limited launched a new hospital mask named F&P Nivairo, for non-invasive ventilation therapy. The key features of the new mask include unique, world-first TubeFit zones, and an advanced seal for ease of set up and patient comfort.

In August 2016, Fisher &Paykel Healthcare Limited announced about updation in its earnings guidance for financial year ending 31 March 2017.The company also announced about the commencement of a new building programme in New Zealand and Mexico.

In August, 2016, Fisher &Paykel Healthcare Limited announced the introduction of an innovative new mask anmed, F&P Brevida. This is a nasal pillows mask designed for the treatment of obstructive sleep apnea (OSA). It features an AirPillow seal which inflates to form a pillow of air in and around the nose for a gentle and effective seal. It also incorporates VisiBlue highlights, which are subtle colour cues to help patients with mask orientation, use and assembly.

Inquiry before buying: databridgemarketresearch.com/inquire-before-buying/?dbmr=...

Table OF Content:
1. INTRODUCTION
1.1. OVERVIEW OF THE SLEEP APNEA DEVICES MARKET

1.2. MARKET SEGMENTATION & COVERAGE

1.2.1. CURRENCY AND PRICING

1.2.2. LIMITATION

2. RESEARCH METHODOLOGY
2.1. KEY TAKEAWAYS

2.2. ARRIVING AT THE GLOBAL SLEEP APNEA DEVICES MARKET SIZE

2.2.1. MARKET CRACKDOWN APPROACH

2.2.2. COMPANY REVENUE AND MARKET SHARE ANALYSIS

2.2.3. DATA TRIANGULATION

2.2.4. KEY DATA POINTS FROM PRIMARY SOURCES

2.2.5. KEY DATA POINTS FROM SECONDARY SOURCES

2.2.6. PORTER’S FIVE FORCES MATRIX

2.2.7. PEST ANALYSIS

2.3. ASSUMPTIONS

2.4. GLOBAL SLEEP APNEA DEVICES MARKET: RESEARCH SNAPSHOT

3. MARKET LANDSCAPE SUMMARY
4. PREMIUM INSIGHTS
4.1. OVERVIEW

4.2. SLEEP APNEA DEVICES MARKET: KEY PRIMARY INSIGHTS

4.3. MARKET OVERVIEW

4.3.1. DRIVERS

4.3.2. RESTRAINTS

4.3.3. OPPURTUNITIES

4.3.4. THREATS

4.4. KEY MARKET TRENDS AND UPCOMING TECHNOLOGIES

5. SLEEP APNEA DEVICES MARKET, BY TYPE
5.1. OVERVIEW

5.2. SLEEP APNEA THERAPEUTIC DEVICES

5.3. SLEEP APNEA DIAGNOSTIC DEVICES

6. SLEEP APNEA THERAPEUTIC DEVICES MARKET, BY PRODUCT TYPE
6.1. OVERVIEW

6.2. POSITIVE AIRWAY PRESSURE DEVICES MARKET (PAP)

6.2.1. CONTINUOUS AIRWAY PRESSURE DEVICES MARKET (CPAP)

6.2.2. BI-LEVEL AIRWAY PRESSURE DEVICES MARKET (BIPAP)

6.2.3. VARIABLE POSITIVE AIRWAY PRESSURE (VPAP)

6.2.4. AUTOMATICALLY-ADJUSTING POSITIVE AIRWAY PRESSURE (APAP)

6.3. MASKS

6.3.1. NON-VENTED MASKS

6.3.2. NASAL MASKS

6.3.3. NASAL PILLOWS

6.3.4. FULL FACE MASKS

6.3.5. PAEDIATRIC MASKS

6.3.6. OTHERS

6.4. ADAPTIVE SERVO-VENTILATION (ASV)

6.5. AIRWAY CLEARANCE SYSTEMS

6.6. OXYGEN CONCENTRATORS

6.6.1. STATIONARY CONCENTRATORS

6.6.2. PORTABLE CONCENTRATORS

6.7. ORAL SLEEP APNEA DEVICES

6.7.1. MANDIBULAR ADVANCEMENT DEVICES (MAD)

6.7.2. TONGUE RETAINING DEVICE (TRD)

6.8. ACCESSORIES

7. SLEEP APNEA DIAGNOSTIC DEVICES MARKET, BY PRODUCT TYPE
7.1. OVERVIEW

7.2. PULSE OXIMETERS

7.2.1. HANDHELD PULSE OXIMETERS

7.2.2. FINGERTIP PULSE OXIMETERS

7.2.3. TABLETOP PULSE OXIMETERS

7.2.4. WRIST-WORN PULSE OXIMETERS

7.3. POLYSOMNOGRAPH (PSG)

7.3.1. CLINICAL PSG

7.3.2. AMBULATORY PSG DEVICES

7.4. RESPIRATORY POLYGRAPH

7.5. ACTIGRAPH

8. SLEEP APNEA DEVICES MARKET, BY END USER
8.1. OVERVIEW

8.2. HOSPITALS

8.3. HOME HEALTHCARE

8.4. SLEEP CLINICS

8.5. COMMUNITY HEALTHCARE

9. SLEEP APNEA DEVICES MARKET, BY APNEA TYPE
9.1. OBSTRUCTIVE SLEEP APNEA

9.1.1. PATIENT VOLUME

9.1.2. MARKET SIZE

9.2. CENTRAL SLEEP APNEA

9.2.1. PATIENT VOLUME

9.2.2. MARKET SIZE

9.3. COMPLEX SLEEP APNEA

9.3.1. PATIENT VOLUME

9.3.2. MARKET SIZE

10. SLEEP APNEA DEVICES MARKET, BY GEOGRAPHY
10.1. COUNTRYWISE SLEEP APNEA DEVICES MARKET, (ALL SEGMENTATION PROVIDED ABOVE IS REPRESENTED IN THIS CHAPTER BY COUNTRY)

10.1.1. NORTH AMERICA

10.1.1.1. U.S.

10.1.1.2. CANADA

10.1.1.3. MEXICO

10.1.2. EUROPE

10.1.2.1. GERMANY

10.1.2.2. FRANCE

10.1.2.3. U.K.

10.1.2.4. ITALY

10.1.2.5. SPAIN

10.1.2.6. RUSSIA

10.1.2.7. TURKEY

10.1.2.8. BELGIUM

10.1.2.9. NETHERLANDS

10.1.2.10. SWITZERLAND

10.1.2.11. REST OF EUROPE

10.1.3. ASIA-PACIFIC (APAC)

10.1.3.1. JAPAN

10.1.3.2. CHINA

10.1.3.3. SOUTH KOREA

10.1.3.4. INDIA

10.1.3.5. AUSTRALIA

10.1.3.6. SINGAPORE

10.1.3.7. THAILAND

10.1.3.8. MALAYSIA

10.1.3.9. INDONESIA

10.1.3.10. PHILIPPINES

10.1.3.11. REST OF APAC

10.1.4. SOUTH AMERICA

10.1.4.1. BRAZIL

10.1.4.2. REST OF LATIN AMERICA

10.1.5. MIDDLE EAST AND AFRICA

10.1.5.1. SAUDI ARABIA

10.1.5.2. REST OF MIDDLE EAST AND AFRICA

10.2. KEY PRIMARY INSIGHTS: BY MAJOR COUNTRIES

11. SLEEP APNEA DEVICES MARKET: COMPETITIVE LANDSCAPE
11.1. GLOBAL SLEEP APNEA DEVICES MARKET: COMPANY SHARE ANALYSIS

11.2. U.S. SLEEP APNEA DEVICES MARKET: COMPANY SHARE ANALYSIS

11.3. EUROPE SLEEP APNEA DEVICES MARKET: COMPANY SHARE ANALYSIS

11.4. APAC SLEEP APNEA DEVICES MARKET: COMPANY SHARE ANALYSIS

11.5. MERGERS & ACQUISITIONS

11.6. NEW PRODUCT DEVELOPMENT & APPROVALS

11.7. EXPANSIONS

11.8. REGULATORY CHANGES

11.9. PARTNERSHIP AND OTHER STRATEGIC DEVELOPMENTS

12. SLEEP APNEA DEVICES MARKET, COMPANY PROFILES
12.1. PHILIPS RESPIRONICS

12.1.1. OVERVIEW

12.1.2. SWOT ANALYSIS

12.1.3. PRODUCT PORTFOLIO

12.1.4. REVENUE ANALYSIS

12.1.5. ANALYSTS VIEW

12.2. RESMED

12.2.1. OVERVIEW

12.2.2. SWOT ANALYSIS

12.2.3. PRODUCT PORTFOLIO

12.2.4. REVENUE ANALYSIS

12.2.5. ANALYSTS VIEW

12.3. FISHER AND PAYKEL HEALTHCARE, LTD.

12.3.1. OVERVIEW

12.3.2. SWOT ANALYSIS

12.3.3. PRODUCT PORTFOLIO

12.3.4. REVENUE ANALYSIS

12.3.5. ANALYST VIEW

12.4. COMPUMEDICS LIMITED

12.4.1. OVERVIEW

12.4.2. SWOT ANALYSIS

12.4.3. PRODUCT PORTFOLIO

12.4.4. REVENUE ANALYSIS

12.4.5. ANALYSTS VIEW

12.5. SOMNOMED

12.5.1. OVERVIEW

12.5.2. SWOT ANALYSIS

12.5.3. PRODUCT PORTFOLIO

12.5.4. REVENUE ANALYSIS

12.5.5. ANALYSTS VIEW

12.6. CAREFUSION CORPORATION

12.6.1. OVERVIEW

12.6.2. SWOT ANALYSIS

12.6.3. PRODUCT PORTFOLIO

12.6.4. REVENUE ANALYSIS

12.6.5. NALYSTS VIEW

12.7. CURATIVE MEDICAL, INC.

12.7.1. OVERVIEW

12.7.2. SWOT ANALYSIS

12.7.3. PRODUCT PORTFOLIO

12.7.4. REVENUE ANALYSIS

12.7.5. ANALYSTS VIEW

12.8. BMC MEDICAL, CO. LTD.

12.8.1. OVERVIEW

12.8.2. SWOT ANALYSIS

12.8.3. PRODUCT PORTFOLIO

12.8.4. REVENUE ANALYSIS

12.8.5. ANALYSTS VIEW

12.9. NATUS MEDICAL, INC.

12.9.1. OVERVIEW

12.9.2. SWOT ANALYSIS

12.9.3. PRODUCT PORTFOLIO

12.9.4. REVENUE ANALYSIS

12.9.5. ANALYSTS VIEW

12.10. DEVILBISS HEALTHCARE

12.10.1. OVERVIEW

12.10.2. SWOT ANALYSIS

12.10.3. PRODUCT PORTFOLIO

12.10.4. REVENUE ANALYSIS

12.10.5. ANALYSTS VIEW

12.11. GLOBAL MEDICAL HOLDINGS, LLC

12.11.1. OVERVIEW

12.11.2. SWOT ANALYSIS

12.11.3. PRODUCT PORTFOLIO

12.11.4. REVENUE ANALYSIS

12.11.5. ANALYSTS VIEW

12.12. ITAMAR MEDICAL, LTD.

12.12.1. OVERVIEW

12.12.2. SWOT ANALYSIS

12.12.3. PRODUCT PORTFOLIO

12.12.4. REVENUE ANALYSIS

12.12.5. ANALYSTS VIEW

12.13. WEINMANN MEDICAL DEVICES GMBH & CO. KG

12.13.1. OVERVIEW

12.13.2. SWOT ANALYSIS

12.13.3. PRODUCT PORTFOLIO

12.13.4. REVENUE ANALYSIS

12.13.5. ANALYSTS VIEW

12.14. SIBELGROUP

12.14.1. OVERVIEW

12.14.2. SWOT ANALYSIS

12.14.3. PRODUCT PORTFOLIO

12.14.4. REVENUE ANALYSIS

12.14.5. ANALYSTS VIEW

12.15. AMBULATORY MONITORING, INC.

12.15.1. OVERVIEW

12.15.2. SWOT ANALYSIS

12.15.3. PRODUCT PORTFOLIO

12.15.4. REVENUE ANALYSIS

12.15.5. ANALYSTS VIEW

12.16. MEDICOM MTD, LTD.

12.16.1. OVERVIEW

12.16.2. SWOT ANALYSIS

12.16.3. PRODUCT PORTFOLIO

12.16.4. REVENUE ANALYSIS

12.16.5. NALYSTS VIEW

12.17. CUSTO MED GMBH

12.17.1. OVERVIEW

12.17.2. SWOT ANALYSIS

12.17.3. PRODUCT PORTFOLIO

12.17.4. REVENUE ANALYSIS

12.17.5. ANALYSTS VIEW

12.18. HEINEN LOWENSTEIN GMBH & CO. KG

12.18.1. OVERVIEW

12.18.2. SWOT ANALYSIS

12.18.3. PRODUCT PORTFOLIO

12.18.4. REVENUE ANALYSIS

12.18.5. ANALYSTS VIEW

12.19. ERGOLINE GMBH

12.19.1. OVERVIEW

12.19.2. SWOT ANALYSIS

12.19.3. PRODUCT PORTFOLIO

12.19.4. REVENUE ANALYSIS

12.19.5. ANALYSTS VIEW

12.20. NEUROVIRTUAL

12.20.1. OVERVIEW

12.20.2. SWOT ANALYSIS

12.20.3. PRODUCT PORTFOLIO

12.20.4. REVENUE ANALYSIS

12.20.5. ANALYSTS VIEW

12.21. BMC MEDICAL CO., LTD.

12.21.1. OVERVIEW

12.21.2. SWOT ANALYSIS

12.21.3. PRODUCT PORTFOLIO

12.21.4. REVENUE ANALYSIS

12.21.5. ANALYSTS VIEW

12.22. SOMNOMEDICS GMBH

12.22.1. OVERVIEW

12.22.2. SWOT ANALYSIS

12.22.3. PRODUCT PORTFOLIO

12.22.4. REVENUE ANALYSIS

12.22.5. ANALYSTS VIEW

12.23. CONTEC MEDICAL SYSTEMS CO.,LTD.

12.23.1. OVERVIEW

12.23.2. SWOT ANALYSIS

12.23.3. PRODUCT PORTFOLIO

12.23.4. REVENUE ANALYSIS

12.23.5. ANALYSTS VIEW

12.24. CLEVELAND MEDICAL DEVICES INC.

12.24.1. OVERVIEW

12.24.2. SWOT ANALYSIS

12.24.3. PRODUCT PORTFOLIO

12.24.4. REVENUE ANALYSIS

12.24.5. ANALYSTS VIEW

12.25. SOMNETICS INTERNATIONAL, INC.

12.25.1. OVERVIEW

12.25.2. SWOT ANALYSIS

12.25.3. PRODUCT PORTFOLIO

12.25.4. REVENUE ANALYSIS

12.24.5. ANALYSTS VIEW

13. APPENDIX
13.1. RELATED REPORTS

13.2. CUSTOMIZABLE OPTIONS

13.3. SOURCE SHEET

13.4. BIBLIOGRAPHY

14. ABOUT DATA BRIDGE MARKET RESEARCH

Other Report

Global Drug Delivery Devices Market – Trends and Forecast to 2024

Global Drug Delivery Devices Market, By Route of Administration (Oral, Injectable, Topical, Pulmonary, Nasal, Ocular, Implantable, Transmucosal), End-User (Hospitals, Clinics, Home Care Settings), Distribution Channel (Direct Tenders,Hospital Pharmacies), Geography (North America, Europe, Asia-Pacific, South America, Middle East Africa) – Trends and Forecast To 2024

Report Access: databridgemarketresearch.com/reports/global-drug-delivery...

About Data Bridge Market Research:
Data Bridge Market Research set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market. Data Bridge endeavors to provide appropriate solutions to the complex business challenges and initiates an effortless decision-making process.

Contact:
Data Bridge Market Research
Tel: +1-888-387-2818
Email: Sales@databridgemarketresearch.com
Investor:investors@databridgemarketresearch.com
Visit Blog databridgemarketresearch.com/blog/
Follow us on LinkedIn: www.linkedin.com/company/data-bridge-market-research

This release was published on openPR.
News-ID: 749011 • Views: 483
More releasesMore releases

You can edit or delete your press release here: